Literature DB >> 8709288

The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent.

T Luo1, J V Garcia.   

Abstract

The nef genes of human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) encode a 27- to 34-kDa myristoylated protein which induces downregulation of CD4 surface levels and enhances virus infectivity. In adult macaques, Nef has been implicated in pathogenesis and disease progression. Both HIV-1 SF2 Nef and SIVmac239 Nef have been shown to associate with a cellular serine/threonine kinase. We tested five functional Nef isolates to examine whether this kinase association is a property conserved among different isolates. HIV-1 SF2 and 248 and SIVmac239 Nef proteins were found associated with the kinase. HIV-1 NL4-3 and 233 Nef proteins were found weakly associated or not associated with the kinase. All five Nef isolates efficiently downregulated CD4 cell surface expression, suggesting that the association with this cellular kinase is not required for Nef to downregulate CD4. Comparison of the SF2 and NL4-3 isolates shows a differential ability of Nef to enhance infectivity that suggests a possible correlation between kinase association and enhancement of infectivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709288      PMCID: PMC190686          DOI: 10.1128/JVI.70.9.6493-6496.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.

Authors:  M Robert-Guroff; M Popovic; S Gartner; P Markham; R C Gallo; M S Reitz
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Authors:  J S Allan; J E Coligan; T H Lee; M F McLane; P J Kanki; J E Groopman; M Essex
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

4.  Structure of simian immunodeficiency virus regulatory genes.

Authors:  S Colombini; S K Arya; M S Reitz; L Jagodzinski; B Beaver; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

Authors:  N R Landau; M Warton; D R Littman
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

6.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM).

Authors:  R Shibata; T Miura; M Hayami; K Ogawa; H Sakai; T Kiyomasu; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  In vitro growth characteristics of simian T-lymphotropic virus type III.

Authors:  M Kannagi; J M Yetz; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  18 in total

1.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

2.  HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.

Authors:  Yoshiko Usami; Heinrich Göttlinger
Journal:  Cell Rep       Date:  2013-10-24       Impact factor: 9.423

3.  Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate.

Authors:  T Luo; J R Downing; J V Garcia
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.

Authors:  Alexa Raney; Lillian S Kuo; Laura L Baugh; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  HIV-1 Nef increases T cell activation in a stimulus-dependent manner.

Authors:  J A Schrager; J W Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin.

Authors:  T Luo; B L Fredericksen; K Hasumi; A Endo; J V Garcia
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase.

Authors:  T Luo; R A Livingston; J V Garcia
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.

Authors:  Bettina Stolp; Libin Abraham; Jochen M Rudolph; Oliver T Fackler
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

9.  Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; J C Grivel; K Suryanarayana; P Meylan; J D Lifson; R Desrosiers; L Margolis
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

10.  Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.

Authors:  W Popik; J E Hesselgesser; P M Pitha
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.